AOD (Spray – AOD-9604)

AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH 176–191), studied in controlled laboratory environments for its interaction with lipid metabolism signaling pathways and adipocyte regulatory models. In experimental research settings, AOD-9604 has been investigated for its influence on lipolysis-associated mechanisms, metabolic pathway modulation, and receptor-mediated signaling frameworks. The nasal spray format is utilized in laboratory research examining intranasal delivery systems and peptide transport dynamics across biological membranes.

Preclinical investigations have examined AOD-9604 for its activity within fatty acid oxidation research models, hormone-fragment signaling pathways, and intracellular metabolic regulation frameworks. Ongoing scientific studies continue to evaluate its molecular stability, receptor interaction characteristics, and downstream signaling behavior under strictly controlled laboratory conditions focused on metabolic research applications.

This research-grade AOD-9604 nasal spray (2mg) is manufactured under strict laboratory-controlled standards. Each batch undergoes analytical verification to confirm molecular identity, purity, and structural consistency. AOD-9604 (Spray) is intended strictly for laboratory research and analytical purposes only and is not for human consumption.